Raymond James Downgrades Quidel's Stock

Dec 14, 2015

NEW YORK (GenomeWeb) – Investment bank Raymond James has downgraded shares of Quidel to Market Perform from Outperform, citing a mild flu season.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Interpace Diagnostics Posts 32 Percent Increase in Q4 Revenues
Streck Prevails in Roche Opposition to NIPT Blood Collection Tube European Patent
Anatolian Hunter-Gatherers Adopted Farming Practices, Ancient DNA Study Suggests
Glaucoma Diagnostic Targeted by Mannin Research, McMaster University Collaboration
NanoString Technologies Plans Common Stock Offering
Oxford Biodynamics Joins UK Prostate Cancer Screening Trial

The Scan

To See More Clearly

Nature News reports that researchers in Japan hope to soon test the use of reprogrammed stem cells to treat damaged corneas.

Which Fish Is Which?

A new approach may help limit the number of fish that are mislabeled at markets or restaurants, according to New Scientist.

The Suspects, Too

At Slate, the R Street Institute's Nila Bala discusses the privacy rights of suspects that genetic genealogy approaches in law enforcement bring up.

This Week in PNAS

In PNAS this week: numerous mobile genetic elements contribute to Vibrio cholerae drug resistance, troponin I mutations in sudden infant deaths, and more.

Menu